PB Fintech Limited has informed the Exchange about Investor Presentation
POLICYBZR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
PB Fintech (Policybazaar + Paisabazaar) hosted its Analyst Day 2026 on May 11, 2026, showcasing four years of strong execution since IPO. Total Insurance Premium grew 4.9x from ₹6,152 Cr (FY22) to ₹29,934 Cr (FY26), with Revenue up 4.8x to ₹6,794 Cr. The company turned profitable in FY24 and posted ₹670 Cr PAT in FY26, guiding to ₹1,000 Cr PAT in FY27. Renewal ARR reached ₹935 Cr at ~80% margins, a 43% CAGR since IPO. Key businesses showed strong momentum: Life premium grew at 32% CAGR, Health fresh grew 68% (3x industry rate), Motor grew 3x the market, and Credit Disbursals reached ₹30,740 Cr. The company set a FY30 target of ₹1 Lac Cr Total Insurance Premium, driven by three compounding levers: the high-margin renewal flywheel, AI/tech leverage, and fixed-cost dilution. PB claims ~40% of all new retail health lives in India and processes 245K+ health claims in FY26.
PB Fintech demonstrates a clear path from high-growth platform to profitable franchise, with the renewal engine providing predictable ~80% margin revenue. The FY30 ₹1 Lac Cr insurance premium target and guided ₹1,000 Cr PAT for FY27 suggest strong earnings trajectory ahead. The stock appears positioned as a compounding business with improving unit economics.